- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare Nippon India Pharma Fund vs Tata India Pharma & Healthcare Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.82 | 2.17 |
NAV | ₹493.23 | ₹29.21 |
Fund Started | 10 May 2004 | 04 Dec 2015 |
Fund Size | ₹8080.97 Cr | ₹1183.65 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 0.25% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.82
2.17
NAV
₹493.23
₹29.21
Fund Started
10 May 2004
04 Dec 2015
Fund Size
₹8080.97 Cr
₹1183.65 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 0.25% if redeemed within 30 days.
Returns
1 Year | 15.46% | 16.60% |
3 Year | 20.03% | 20.25% |
5 Year | 22.09% | 21.63% |
1 Year
15.46%
16.60%
3 Year
20.03%
20.25%
5 Year
22.09%
21.63%
Holding Analysis
Equity | 99.48% | 95.78% |
Cash | 0.52% | 4.22% |
Equity
99.48%
95.78%
Cash
0.52%
4.22%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.43% |
Divi's Laboratories Ltd. | 9.28% |
Lupin Ltd. | 7.27% |
Cipla Ltd. | 5.71% |
Apollo Hospitals Enterprise Ltd. | 5.31% |
Dr. Reddy's Laboratories Ltd. | 5.19% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.61% |
Vijaya Diagnostic Centre Ltd. | 3.53% |
Abbott India Ltd. | 3.46% |
Medplus Health Services Ltd. | 3.41% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.79% |
Aurobindo Pharma Ltd. | 7.27% |
Cipla Ltd. | 5.97% |
Apollo Hospitals Enterprise Ltd. | 5.66% |
Lupin Ltd. | 5.20% |
Divi's Laboratories Ltd. | 5.12% |
Fortis Healthcare Ltd. | 5.05% |
Aster DM Healthcare Ltd. | 3.91% |
Dr. Reddy's Laboratories Ltd. | 3.50% |
Wockhardt Ltd. | 3.31% |
Fund Manager
Name | Akshay Sharma | Meeta Shetty |
Start Date | 01 Dec 2022 | 09 Nov 2018 |
Name
Akshay Sharma
Meeta Shetty
Start Date
01 Dec 2022
09 Nov 2018
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. |
Launch Date | 10 May 2004 | 04 Dec 2015 |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Launch Date
10 May 2004
04 Dec 2015